NanoCarrier Co., Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Chiba Japan (1996)
Status: No NME R&D (1996)

Organization Overview

First Clinical Trial
2009
NCT00910741
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

NanoCarrier Co., Ltd. | NanoCarrier US LLC